This is an incurable leukaemia of CD4 positive T cells which is found in association with HTLV infection.
The life-time risk of developing adult T-cell leukaemia in an individual who is infected with HTLV is 2-5%. The risk of leukaemia is greater in patients who are infected during infancy.
Anti-neoplastic therapy typically comprises combination cytotoxic chemotherapy. Other therapies aim to interfere with HTLV replication e.g. zidovudine + alpha-interferon.
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.